Plus the interpretation is super straight forward: CI contains zero: Not significant. If nothing else, we should make CIs the primary default instead of p-values.
But yes, you usually do have some information and it is net better to encode when possible.
If anything I wrote appeared to be saying "just look at effect size, it's the only thing that matters" then that was an error on my part. I definitely didn't intend to say that.
But I was responding to an article saying "p<0.05 considered harmful" that never mentions effect sizes at all. I think that's enough to demonstrate that, in context, "it's bad to look at p-values and ignore effect sizes" is not in fact a straw man.
Incidentally, I am not convinced that the p-value as such is often a good way to assess how likely it is that your results are due to random chance. Suppose you see an effect size of 1 unit with p=0.05. OK, so there's a 5% chance of getting these results if the true effect size is zero. But you should also care what the chance is of getting these results if the true effect size is +0.1. (Maybe the distribution of errors is really weird and these results are very likely with a positive but much smaller effect size; then you have good evidence against the null hypothesis but very weak evidence for an effect size of the magnitude you measured.) In fact, what you really want to know is what the probability is for every possible effect size, because that gives you the likelihood ratios you can use to decide how likely you think any given effect size is after seeing the results. For sure, having the p-value is better than having nothing, but if you were going to pick one statistic to know in addition to (say) a point estimate of the effect size, it's not at all clear that the p-value is what you should choose.
It would be cool if interfaces caught up so I could just draw a basic estimate of my prior and then see the posterior graph afterwards.
p-values were created to facilitate rigorous inference with minimal computation, which was the norm during the first half of the 20th century. For those who work on a frequentist framework, inference should be done using a likelihood-based approach plus model selection, e.g. AIC. It's makes it much harder to lie.
Best practice (as I understand it) is to fix the model ahead of time, before seeing the data, if possible (as in a randomized controlled trial of a new medicine, etc.).
The only question is… would you rather be up front and explicit about your assumptions, or not?
An uninformative prior is an assumption, even if it’s the one that doesn’t bias the posterior (note that here “bias” is not a bad word).
I'm also not sure why everyone perceived my comment as anti-bayesian.
But are you sure you know what I meant when I said “uninformative prior”? Because choosing an uninformative prior does not involve choosing any parameters: there is only one uninformative prior, and it’s the constant (flat) distribution which assigns equal probability to every value. It encodes no information and does not bias the posterior or result. It is the one and only mathematically-neutral prior. You can think of it as being a bit like an “identity function”.
Ultimately, I think you are strawmanning frequentism here. Just because the log likelihood is sometimes the same as the map does not imply that they have the same meaning. This is why computed uncertainties of both approaches are often not the same and have a not-so-subtle difference in their interpretation. The one computes uncertainty in belief, the other imprecision of an experiment. You can't summarize that with "do you want to be explicit about assumptions".
I am not straw-manning anything: bayesian methods are a generalization of frequentist methods. The equality / isomorphism to frequentist methods, in the special case of the uninformative prior, is commonly demonstrated in introductory (undergrad-level) bayesian textbooks and is in fact trivial. One need not even talk of any infinities: if you’re doing discrete observations, infinities never show up (and in that case the prior normalizes just fine). And if you’re curve-fitting (ie.: using parametric methods), the “infinite” line goes away as soon as you multiply your uninformative prior with your likelihood.
Ive worked with clinical trials and nobody says “oh, p < 0.05 so we should use this drug”.
Doctors do a much more sophisticated deep dive into the data and statistical significance is maybe 1 of a 10 factors they consider.
And hell, even if it is statistically significant, doctors may not use a drug for many other reasons.
It seems like the people who criticize p-values aren't that familiar with how they are actually used.
Consider effect sizes - this seems to be a completely different (yes important) question. Obviously the magnitude of the impact of the drug is important - but it isn't a replacement or "something to look at instead of p-value" because the chance that the results you saw are due to random variation is still important! You can see a massive effect size but if that is totally expected within your null model, then it is probably not all that exciting!
Effect sizes are a complement to some sort of hypothesis testing, but they are not a replacement.
> Prior probability.
yes, when you can effectively encode your prior probability I would say the posterior probability of seeing what you did is at least as good as p-value.